Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300
Bang, Y.-J, Ruiz, E.Yañez, Van Cutsem, E., Lee, K.-W, Wyrwicz, L., Schenker, M., Alsina, M., Ryu, M.-H, Chung, H.-C, Evesque, L., Al-Batran, S.-E, Park, S.H., Lichinitser, M., Boku, N., Moehler, M.H., Hong, J., Xiong, H., Hallwachs, R., Conti, I., Taieb, J.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Gender medicine and oncology: report and consensus of an ESMO workshop
Wagner, A.D., Oertelt-Prigione, S., Adjei, A., Buclin, T., Cristina, V., Csajka, C., Coukos, G., Dafni, U., Dotto, G.-P., Ducreux, M., Fellay, J., Haanen, J., Hocquelet, A., Klinge, I., Lemmens, V., Letsch, A., Mauer, M., Moehler, M., Peters, S., Özdemir, B.C.
Published in Annals of oncology (01.12.2019)
Published in Annals of oncology (01.12.2019)
Get full text
Journal Article
Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial
Stintzing, S., Wirapati, P., Lenz, H.-J., Neureiter, D., Fischer von Weikersthal, L., Decker, T., Kiani, A., Kaiser, F., Al-Batran, S., Heintges, T., Lerchenmüller, C., Kahl, C., Seipelt, G., Kullmann, F., Moehler, M., Scheithauer, W., Held, S., Modest, D.P., Jung, A., Kirchner, T., Aderka, D., Tejpar, S., Heinemann, V.
Published in Annals of oncology (01.11.2019)
Published in Annals of oncology (01.11.2019)
Get full text
Journal Article
Impact of BRAF and RAS mutations on first-line efficacy of FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab: analysis of the FIRE-3 (AIO KRK-0306) study
Stintzing, S, Miller-Phillips, L, Modest, D.P, Fischer von Weikersthal, L, Decker, T, Kiani, A, Vehling-Kaiser, U, Al-Batran, S.-E, Heintges, T, Kahl, C, Seipelt, G, Kullmann, F, Stauch, M, Scheithauer, W, Held, S, Moehler, M, Jagenburg, A, Kirchner, T, Jung, A, Heinemann, V
Published in European journal of cancer (1990) (01.07.2017)
Published in European journal of cancer (1990) (01.07.2017)
Get full text
Journal Article
Prognostic factors for progression-free and overall survival in advanced biliary tract cancer
Bridgewater, J., Lopes, A., Wasan, H., Malka, D., Jensen, L., Okusaka, T., Knox, J., Wagner, D., Cunningham, D., Shannon, J., Goldstein, D., Moehler, M., Bekaii-Saab, T., McNamara, M.G., Valle, J.W.
Published in Annals of oncology (01.01.2016)
Published in Annals of oncology (01.01.2016)
Get full text
Journal Article
Prognostic Significance of Focal Lesions in Whole-Body Magnetic Resonance Imaging in Patients With Asymptomatic Multiple Myeloma
HILLENGASS, Jens, FECHTNER, Kerstin, HO, Anthony D, KAUCZOR, Hans-Ulrich, DELORME, Stefan, GOLDSCHMIDT, Hartmut, WEBER, Marc-André, BÄUERLE, Tobias, AYYAZ, Sofia, HEISS, Christiane, HIELSCHER, Thomas, MOEHLER, Thomas M, EGERER, Gerlinde, NEBEN, Kai
Published in Journal of clinical oncology (20.03.2010)
Published in Journal of clinical oncology (20.03.2010)
Get full text
Journal Article
Cetuximab plus cisplatin–5-fluorouracil versus cisplatin–5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie
Lorenzen, S., Schuster, T., Porschen, R., Al-Batran, S.-E., Hofheinz, R., Thuss-Patience, P., Moehler, M., Grabowski, P., Arnold, D., Greten, T., Müller, L., Röthling, N., Peschel, C., Langer, R., Lordick, F.
Published in Annals of oncology (01.10.2009)
Published in Annals of oncology (01.10.2009)
Get full text
Journal Article
Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER)
Moehler, M., Maderer, A., Thuss-Patience, P.C., Brenner, B., Meiler, J., Ettrich, T.J., Hofheinz, R.-D., Al-Batran, S.E., Vogel, A., Mueller, L., Lutz, M.P., Lordick, F., Alsina, M., Borchert, K., Greil, R., Eisterer, W., Schad, A., Slotta-Huspenina, J., Van Cutsem, E., Lorenzen, S.
Published in Annals of oncology (01.02.2020)
Published in Annals of oncology (01.02.2020)
Get full text
Journal Article
Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer
Harder, J, Ihorst, G, Heinemann, V, Hofheinz, R, Moehler, M, Buechler, P, Kloeppel, G, Röcken, C, Bitzer, M, Boeck, S, Endlicher, E, Reinacher-Schick, A, Schmoor, C, Geissler, M
Published in British journal of cancer (13.03.2012)
Published in British journal of cancer (13.03.2012)
Get full text
Journal Article
Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: A double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme
Moehler, M, Maderer, A, Schimanski, C, Kanzler, S, Denzer, U, Kolligs, F.T, Ebert, M.P, Distelrath, A, Geissler, M, Trojan, J, Schütz, M, Berie, L, Sauvigny, C, Lammert, F, Lohse, A, Dollinger, M.M, Lindig, U, Duerr, E.M, Lubomierski, N, Zimmermann, S, Wachtlin, D, Kaiser, A.-K, Schadmand-Fischer, S, Galle, P.R, Woerns, M
Published in European journal of cancer (1990) (01.12.2014)
Published in European journal of cancer (1990) (01.12.2014)
Get full text
Journal Article
Standardized and quality-assured predictive PD-L1 testing in the upper gastrointestinal tract
Baretton, Gustavo B., Lordick, Florian, Gaiser, T., Hofheinz, R., Horst, D., Lorenzen, S., Moehler, M., Röcken, C., Schirmacher, P., Stahl, M., Thuss-Patience, P., Tiemann, K.
Published in Journal of cancer research and clinical oncology (01.11.2023)
Published in Journal of cancer research and clinical oncology (01.11.2023)
Get full text
Journal Article
Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II study
Moehler, M., Mueller, A., Trarbach, T., Lordick, F., Seufferlein, T., Kubicka, S., Geißler, M., Schwarz, S., Galle, P.R., Kanzler, S.
Published in Annals of oncology (01.06.2011)
Published in Annals of oncology (01.06.2011)
Get full text
Journal Article
Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer
Trarbach, T, Moehler, M, Heinemann, V, Köhne, C-H, Przyborek, M, Schulz, C, Sneller, V, Gallant, G, Kanzler, S
Published in British journal of cancer (02.02.2010)
Published in British journal of cancer (02.02.2010)
Get full text
Journal Article
Relation of cetuximab-induced skin toxicity and early tumor shrinkage in metastatic colorectal cancer patients: results of the randomized phase 3 trial FIRE-3 (AIO KRK0306)
Holch, J.W., Held, S., Stintzing, S., Fischer von Weikersthal, L., Decker, T., Kiani, A., Kaiser, F., Heintges, T., Kahl, C., Kullmann, F., Scheithauer, W., Moehler, M., von Einem, J.C., Michl, M., Heinemann, V.
Published in Annals of oncology (01.01.2020)
Published in Annals of oncology (01.01.2020)
Get full text
Journal Article
Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trial
KROPFF, Martin, GIONGCO BAYLON, Honorata, AVET-LOISEAU, Herve, MOEHLER, Thomas M, PATTOU, Claire, LUCY, Lela, KUEENBURG, Elisabeth, GLASMACHER, Axel, ZERBIB, Robert, FACON, Thierry, HILLENGASS, Jens, ROBAK, Tadeusz, HAJEK, Roman, LIEBISCH, Peter, GORANOV, Stefan, HULIN, Cyrille, BLADE, Joan, CARAVITA, Tommaso
Published in Haematologica (Roma) (01.05.2012)
Published in Haematologica (Roma) (01.05.2012)
Get full text
Journal Article
Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4
SCHIMANSKI, C. C, BAHRE, R, SCHULER, M, ACHENBACH, T, JUNGINGER, T, GALLE, P. R, MOEHLER, M, GOCKEL, I, MÜLLER, A, FRERICHS, K, HÖRNER, V, TEUFEL, A, SIMIANTONAKI, N, BIESTERFELD, S, WEHLER, T
Published in British journal of cancer (17.07.2006)
Published in British journal of cancer (17.07.2006)
Get full text
Journal Article
Mismatch repair deficiency, chemotherapy and survival for resectable gastric cancer: an observational study from the German staR cohort and a meta-analysis
Stolze, T., Franke, S., Haybaeck, J., Moehler, M., Grimminger, P. P., Lang, H., Roth, W., Gockel, I., Kreuser, N., Bläker, H., Wittekind, C., Lordick, F., Vieth, M., Veits, L., Waidmann, O., Lingohr, P., Peitz, U., Schildberg, C., Kruschewski, M., Vassos, N., Goni, E., Bruns, C. J., Ridwelski, K., Wolff, S., Lippert, H., Schumacher, J., Malfertheiner, P., Venerito, M.
Published in Journal of cancer research and clinical oncology (01.03.2023)
Published in Journal of cancer research and clinical oncology (01.03.2023)
Get full text
Journal Article
LBA6_PR Nivolumab (nivo) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC)/esophageal adenocarcinoma (EAC): First results of the CheckMate 649 study
Moehler, M., Shitara, K., Garrido, M., Salman, P., Shen, L., Wyrwicz, L., Yamaguchi, K., Skoczylas, T., Campos Bragagnoli, A., Liu, T., Schenker, M., Yanez, P., Tehfe, M., Poulart, V., Cullen, D., Lei, M., Kondo, K., Li, M., Ajani, J.A., Janjigian, Y.Y.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Advances in the management of hepatobiliary and pancreatic malignancies: highlights from the ESMO Annual Meeting 2023 by the EORTC GI Tract Cancer Group
C. Fulgenzi, I. Garajová, M. Moehler, M.P. Lutz, E. Smyth, L. Rimassa, C. Neuzillet, A. Lamarca
Published in ESMO Gastrointestinal Oncology (01.03.2024)
Published in ESMO Gastrointestinal Oncology (01.03.2024)
Get full text
Journal Article
An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer
Moehler, M, Mueller, A, Hartmann, J.T, Ebert, M.P, Al-Batran, S.E, Reimer, P, Weihrauch, M, Lordick, F, Trarbach, T, Biesterfeld, S, Kabisch, M, Wachtlin, D, Galle, P.R
Published in European journal of cancer (1990) (01.07.2011)
Published in European journal of cancer (1990) (01.07.2011)
Get full text
Journal Article